Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1997
RATIONALE: Drugs like liposomal amphotericin B may be able to relieve fungal infection which can be a side effect of chemotherapy. Colony-stimulating factors such as sargramostim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person\'s immune system recover from the side effects of chemotherapy. It is not yet known whether receiving liposomal amphotericin B plus sargramostim is more effective than receiving liposomal amphotericin B alone in treating patients with invasive fungal infection. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of liposomal amphotericin B with or without sargramostim in treating patients with invasive fungal infection.
Epistemonikos ID: 6e56ec031c854f86b69e8071bb8ad7f183f6513c
First added on: May 03, 2024